These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10140634)

  • 41. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 42. Hospice. Can it work within managed care?
    Lemkin P
    Caring; 1997 Aug; 16(8):20-3. PubMed ID: 10170051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reinventing the PBM (pharmacy benefit manager).
    Marcille JA; Wynn P
    Manag Care; 1997 Apr; 6(4):64-6, 75-8. PubMed ID: 10167003
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
    Fendrick AM; Smith DG; Chernew ME; Shah SN
    Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing provider networks through expert systems: use of patterns of treatment to address overutilization.
    Miller LG
    Physician Exec; 1994 May; 20(5):44-5. PubMed ID: 10134064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review: feedback about practice patterns for measurable improvements in quality of care--a challenge for PROs under the Health Care Quality Improvement Program.
    Hayes RP; Ballard DJ
    Clin Perform Qual Health Care; 1995; 3(1):15-22. PubMed ID: 10141395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of managed care and financing in medical practices: how does psychiatry differ from other medical fields?
    Sturm R; Ringel JS
    Soc Psychiatry Psychiatr Epidemiol; 2003 Aug; 38(8):427-35. PubMed ID: 12910338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM; Meyer JD; Kelly WN
    Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Designing and implementing an effective specialty pharmacy service program.
    Morrow TJ
    Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of a practice-based, multimodal quality improvement intervention for gastroenteritis within a Medicaid managed care network.
    Zolotor AJ; Randolph GD; Johnson JK; Wegner S; Edwards L; Powell C; Esporas MH
    Pediatrics; 2007 Sep; 120(3):e644-50. PubMed ID: 17766504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Get the most out of your PBM (pharmacy benefit manager).
    Mandelker J
    Bus Health; 1994 Nov; 12(11):37-42. PubMed ID: 10138533
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselves.
    Condron JH; Mann JL
    Can J Hosp Pharm; 1994 Oct; 47(5):203-8. PubMed ID: 10137698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspective.
    Thomas N
    Pharmacoeconomics; 1996; 9 Suppl 1():9-15. PubMed ID: 10160115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions.
    Grabowski H; Mullins CD
    Soc Sci Med; 1997 Aug; 45(4):535-44. PubMed ID: 9226779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective screening of diagnostic testing: a valuable tool.
    Finkel ML
    Benefits Q; 1992; 8(1):28-33. PubMed ID: 10117176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to tie a drug therapy improvement program to physician credentialing.
    Tse CS; Roecker W; Benitez M; Musabji M
    Hosp Formul; 1994 Sep; 29(9):646-50, 656. PubMed ID: 10137061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A conversation with Debra Dullinger, PharmD.
    Dullinger D
    Med Interface; 1994 Oct; 7(10):71-4. PubMed ID: 10137568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.